Seer Board Rejects CEO's $2.45/Share Buyout Bid, Citing Undervaluation
SEER sits 32% above its 52-week low of $1.55.
Summary
Seer's board rejected a $2.45/share buyout proposal from its own CEO, calling it inadequate — the latest twist in a months-long fight for control of the proteomics company.
Key Events · M&A and Partnerships · SEER
-
CEO Launches Buyout Bid
On July 1, 2026, CEO Omid Farokhzad submitted an unsolicited, non-binding proposal to acquire all outstanding Class A common stock for $2.45 per share in cash plus two contingent value rights.
-
Special Committee Rejects Offer
The independent Special Committee, comprising Meeta Gulyani and Nicolas Roelofs, unanimously rejected the proposal on July 20, 2026, determining it undervalues Seer and that the CVRs are insufficient to capture long-term growth prospects.
-
Escalation of Control Battle
This CEO-led bid follows months of activist pressure from Radoff-JEC Group, including multiple rejected offers — the last at $2.40 per share — and an ongoing proxy contest to elect three new directors.
-
Premium to Market, but Board Sees More Value
The $2.45 offer represents a 20% premium to the current $2.04 stock price, yet the board's rejection signals confidence in a higher intrinsic value, raising stakes ahead of the annual meeting.
Analysis · SEER · Industrial Applications And Services
An independent Special Committee of Seer's board unanimously turned down an unsolicited, non-binding acquisition proposal from CEO Omid Farokhzad at $2.45 per share in cash plus two contingent value rights. Advised by independent counsel, the committee concluded the offer undervalues the company and that the CVR structure fails to capture its long-term growth potential. The move dramatically escalates Seer's ongoing control battle: the CEO himself is now attempting to take the company private, just months after the board fought off a proxy contest and multiple bids from activist Radoff-JEC Group. While the $2.45 offer sits only slightly above the activists' last $2.40 bid, the board's swift rejection signals confidence in a higher standalone value. With the stock at $2.04, the rejected premium represents a 20% upside, yet the board is effectively telling shareholders the company is worth more — a high-stakes gamble that will be tested at the upcoming annual meeting, where activist-nominated directors are on the ballot.
At the time of this filing, SEER was trading at $2.04 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $112.8M. The 52-week trading range was $1.55 to $2.41. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.